# Neuroscience company earnings and analyst updates

> Live situation record from CLSTR: https://clstr.news/situations/neuroscience-company-earnings-and-analyst-updates
> Updated: 2026-08-19T12:12:51.000Z. Sources: 2. Developments: 2.

Analysts have updated earnings per share (EPS) estimates for neuroscience-focused companies Promis Neurosciences and NeuroPace. 

Brookline Capital Markets raised the Q3 2026 EPS forecast for Promis Neurosciences to ($1.29) from ($2.41), following a reported Q3 loss of ($1.28) per share which exceeded consensus estimates. The firm maintains a ‘Strong-Buy’ rating. 

Meanwhile, HC Wainwright lowered its Q3 2027 EPS estimate for NeuroPace to $0.05 per share from $0.06, while maintaining a ‘Buy’ rating and a $20.00 price objective.

## Timeline

### 2026-08-19: Promis Neurosciences and NeuroPace see updated analyst earnings estimates

Analysts have adjusted earnings per share estimates for Promis Neurosciences and NeuroPace, with Brookline Capital Markets raising forecasts for the former and HC Wainwright lowering them for the latter.

2 sources. https://clstr.news/cluster/promis-neurosciences-and-neuropace-see-updated-analyst-earnings-estimates

### 2026-08-03: NeuroOne, Paylocity, Neuronetics, Personalis, and Cooper Standard Schedule Upcoming Earnings Calls

NeuroOne, Paylocity, Neuronetics, Personalis, and Cooper Standard announce upcoming earnings releases and investor webcast events in August 2026.

7 sources. https://clstr.news/cluster/neuroone-medical-technologies-and-eton-pharmaceuticals-schedule-august-13-earnings-releases

---
Cite as: Neuroscience company earnings and analyst updates. CLSTR, https://clstr.news/situations/neuroscience-company-earnings-and-analyst-updates